Georgetown Lombardi Comprehensive Cancer Center

Search
This image is a collage of the Georgetown Lombardi Cancer Center and partners. It shows clinical and research images of center.

Comprehensive Research

Georgetown Lombardi, Washington's only National Cancer Institute-designated Comprehensive Cancer Center, works with other institutions - MedStar Health and the John Theurer Cancer Center - to broaden its research capacity.

Learn About Our Partnerships

Image of the Georgetown University Medical and Dental building taken in the evening

Research

We are developing and testing the cancer treatments of tomorrow - targeted therapies that will improve both survival and quality of life.

About Our Research

Image of cancer patient in a hospital bed, with a family member standing next to the bed

Patient Care

Award-winning physicians, state-of-the-art facilities, and a high commitment to excellence—qualities that make Lombardi stand out above the rest!

About Patient Care

Professor giving a presentation to students from the Georgetown University School of Medicine

Education

Educating and training tomorrow's leaders in cancer treatment and research is our mission.

About Education

President DeGoia speaking of the importance of Geogetown Lombardi's NCI designationWhat makes Georgetown Lombardi Comprehensive Cancer Center different from other cancer centers? Georgetown University President John J. DeGioia shares his thoughts on the important work at Washington’s only National Cancer Institute-designated Comprehensive Cancer Center.

Watch President DeGioia's discussion

Closeup image of a microscope in a lab
Disease Specialties
Image of a doctor walking in the hallway of a hospital
Clinical Departments
Wooden red medical heart in the palm of a persons hands
PartnershiPS
Image of road leading to the Georgetown University Medical and Dental building
Lombardi intranet
Closeup image of hard covered books on a library shelf.
Shared Resources
Medical students getting a tour of a lab at Georgetown University Medical Center
Subscribe

Partners and Resources. Georgetown Lombardi draws upon resources of Georgetown University Medical Center (GUMC), partners with MedStar Georgetown University Hospital, and houses world-class research centers.

School of Medicine School of Nursing and Health Studies Georgetown Lombardi Comprehensive Cancer Center Biomedical Graduate Research Organization MedStar Georgetown University Hospital
Capital Breast Care Center (CBCC) Fisher Center for Hereditary Cancer and Clinical Genomics Research Innovation Center for Biomedical Informatics Nina Hyde Center for Breast Cancer Research The Ruesch Center for the Cure of Gastrointestinal Cancers

OncLive Strategic Alliance BadgeOncLive

OncLive and Georgetown Lombardi collaborate through OncLive's Strategic Alliance Partnership initiative

OncLive's Strategic Alliance

Lombardi News Stories

  • A man in a white coat is speaking
    Research in a Minute: Giuseppe Giaccone, MD, PhD

    As associate director of clinical research at Georgetown Lombardi Comprehensive Cancer Center and professor of medical oncology and pharmacology at Georgetown University School of Medicine, Giuseppe Giaccone, MD, PhD, leads a team of researchers in studying thymic carcinoma, also known as cancer of the thymus.

  • A brick sign for Frederick National Laboratory sits in a landscaped area outdoors
    Frederick National Laboratory and Georgetown Launch Research and Education Collaboration

    A new collaboration between Georgetown University and the Frederick National Laboratory for Cancer Research in Frederick, Maryland, aims to expand both institutions’ research and training missions in the biomedical sciences.

  • Image of the Georgetown University Medical and Dental building taken in the evening
    Family History Increases Breast Cancer Risk Even in Older Women: Weighing Screening Options

    Family history of breast cancer continues to significantly increase chances of developing invasive breast tumors in women ages 65 and older, according to research published by a team led by Dejana Braithwaite, PhD, associate professor of oncology at Georgetown University School of Medicine and a member of Georgetown Lombardi Comprehensive Cancer Center.

  • The Med-Dent building bathed in the fading light of day
    New Immunotherapy Combination Tolerable, Effective in Patients with Advanced Kidney Cancer

    A study led by Michael B. Atkins, MD, deputy director, Georgetown Lombardi Comprehensive Cancer Center, that combined an agent that blocks blood vessel formation with an immunotherapy agent was found to have promising anti-tumor activity and no unexpected side effects in an early-phase clinical trial in patients with advanced kidney cancer who had not been previously treated.